Журнал «Паллиативная медицина и реабилитация»
№
2. 2016 г.
39
Matrifen and DurogesicDTrans are bioequivalent. Eur J
PharmBiopharm 2010;75(2):225-31.
11. Freynhagen R, von Giesen HJ, Busche P, Sabatowski R,
Konrad C, Grond S. Switching from reservoir to matrix
systems for the transdermal delivery of fentanyl: a prospective,
multicenter pilot study in outpatients with chronic pain. J
PainSymptomManage 2005;30(3):289-97.
12. Kang JH, Oh SY, Song SY, Lee HY, Kim JH, Lee KE, et al.
The efficacy of low-dose transdermal fentanyl in opioid-naive
cancer patients with moderate-to-severe pain. Korean J
InternMed 2015;30(1):88-95.
13. Инструкция по применению препарата Фенвидия.
14. AhmedzaiS,
BrooksD,
onbehalfoftheTTS-
FentanylComparativeTrialGroup. Transdermal fentanyl versus
sustained-release oral morphine in cancer pain: preference,
efficacy, and quality of Life. JPainSymptomManage
1997;13:254-61.
15. vanSeventer R1, Smit JM, Schipper RM, Wicks MA, Zuurmond
WW. Comparison of TTS-fentanyl with sustained-release oral
morphine in the treatment of patients not using opioids for
mild-to-moderate pain.CurrMedResOpin 2003;19(6):457-69.
16. MystakidouK, ParpaE, TsilikaE, KatsoudaE, KoulouliasV,
KouvarisJ, etal. Pain management of cancer patients with
transdermal fentanyl: a study of 1828 step I, II, & III transfers.
JPain 2004;5(2):119-32.
17. Clark AJ, Ahmedzai SH, Allan LG, Camacho F, Horbay GL,
Richarz U, Simpson K. Efficacy and safety of transdermal
fentanyl and sustained-release oral morphine in patients with
cancer and chronic non-cancer pain.CurrMedResOpin
2004;20(9):1419-28.
18. Yang Q, Xie DR, Jiang ZM, Ma W, Zhang YD, Bi ZF, Chen
DL. Efficacy and adverse effects of transdermal fentanyl and
sustained-release oral morphine in treating moderate-severe
cancer pain in Chinese population: a systematic review and
meta-analysis.JExpClinCancerRes 2010;29:67.
19. HadleyG, DerryS, MooreRA, WiffenPJ. Transdermal fentanyl
for cancer pain. Cochrane Database Syst Rev 2013 Oct
5;10:CD010270.
20. Kress HG, der Laage D, Hoerauf K, Nolte T, Heiskanen T,
Petersen R, et al. A randomized, open, parallel group,
multicenter trial to investigate analgesic efficacy and safety of a
new transdermal fentanyl patch compared to standard opioid
treatment in cancer pain. JPainSympManag 2008;36(3):269-
79.
21. Langford R, McKenna F, Ratcliffe S, Vojtassak J, Richarz U.
Transdermal fentanyl for improvement of pain and functioning
in osteoarthritis: a randomized, placebo-controlled trial.
ArthritisRheum 2006;54(6):1829-37.
22. OhtoriS, InoueG, OritaS, EguchiY, OchiaiN, KishidaS,
TakasoM, etal. Transdermal fentanyl for chronic low back
pain.Yonsei Med J 2012;53(4):788-93.
23. DellemijnPL, vanDuijnH, VannesteJA. Prolonged treatment
with transdermal fentanyl in neuropathic pain. J Pain Symptom
Manage 1998;16:220-9.
Поступила 24.03.2016 г.
s
